UroGen Pharma Ltd. earnings per share and revenue

URGN earnings per share for the last quarter are -0.72 USD whereas the estimation was -0.68 USD which accounts for -5.88% surprise. Företagets omsättning för samma period uppgår till 23.53 M USD trots den uppskattade siffran 22.57 M USD. Estimated earnings per share for the next quarter are -0.87 USD, and revenue is expected to reach 21.39 M USD. Also watch annual changes over time to get a bigger picture of URGN earnings per share and revenue dynamics.